Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | Y376C |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | FGFR2 Y376C (corresponds to Y375C in the canonical isoform) lies within the extracellular domain of the Fgfr2 protein (PMID: 17525745). Y376C results in constitutive dimerization through inter-molecular disulfide bonds (PMID: 17525745), and therefore, is predicted to lead to a gain of Fgfr2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
FGFR2 mutant FGFR2 act mut FGFR2 Y376C |
Transcript | NM_022970.4 |
gDNA | chr10:g.121515280T>C |
cDNA | c.1127A>G |
Protein | p.Y376C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001144913 | chr10:g.121515280T>C | c.1127A>G | p.Y376C | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121515280T>C | c.1127A>G | p.Y376C | RefSeq | GRCh38/hg38 |
NM_022970.4 | chr10:g.121515280T>C | c.1127A>G | p.Y376C | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121515280T>C | c.1127A>G | p.Y376C | RefSeq | GRCh38/hg38 |
NM_022970.3 | chr10:g.121515280T>C | c.1127A>G | p.Y376C | RefSeq | GRCh38/hg38 |
NM_022970 | chr10:g.121515280T>C | c.1127A>G | p.Y376C | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01888562 | Phase I | Ponatinib | Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma | Withdrawn | 0 |